Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Research

Background:

• Macromolecules show promise in cancer immunotherapy but face challenges like poor stability and cellular uptake.
• Traditional synthetic carriers for macromolecule delivery have limitations including off-target effects.

Purpose of the Study:

• To review the unique features of extracellular vesicles (EVs) for macromolecule delivery.
• To discuss strategies and recent advances in using EVs for cancer immunotherapy.

Main Methods:

• Literature review focusing on extracellular vesicles (EVs) as delivery vehicles.
• Analysis of EV characteristics relevant to macromolecule transport.
• Synthesis of recent findings on EV-mediated cancer immunotherapy.

Main Results:

• Extracellular vesicles (EVs) provide stable, efficient, and selective delivery of macromolecules.
• EVs enhance the efficacy and potential of macromolecular drugs in cancer immunotherapy.
• Naturally derived EVs overcome limitations associated with synthetic delivery systems.

Conclusions:

• Extracellular vesicles (EVs) represent a significant advancement in drug delivery for cancer immunotherapy.
• EVs offer a viable and effective alternative to synthetic carriers for macromolecule delivery.
• Further research into EV-based strategies can optimize cancer treatment outcomes.